Amgen-23

CAS No. 1448706-15-7

Amgen-23( —— )

Catalog No. M35699 CAS No. 1448706-15-7

Amgen-23 is a selective and highly potent sphingosine kinase 1 (SPHK1) inhibitor that inhibits SPHK2 and can be used in anticancer research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 128 Get Quote
5MG 188 Get Quote
10MG 321 Get Quote
25MG 625 Get Quote
50MG 916 Get Quote
100MG 1557 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Amgen-23
  • Note
    Research use only, not for human use.
  • Brief Description
    Amgen-23 is a selective and highly potent sphingosine kinase 1 (SPHK1) inhibitor that inhibits SPHK2 and can be used in anticancer research.
  • Description
    Amgen-23 (compound 23) is a potent sphingosine kinases (SPHK) inhibitor with IC50 values of 20 nM and 1.6 μM for SPHK1 and SPHK2, respectively. Amgen-23 can be used for researching anticancer.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    S1P Receptor
  • Recptor
    S1P Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1448706-15-7
  • Formula Weight
    478.44
  • Molecular Formula
    C23H25Cl2N3O2S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (209.02 mM; Ultrasonic )
  • SMILES
    N(C1=NC(=CS1)C2=CC(Cl)=C(Cl)C=C2)C3=CC=C(CCN4[C@@H](CO)C[C@@H](O)CC4)C=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Gustin DJ, et al. Structure guided design of a series of sphingosine kinase (SphK) inhibitors. Bioorg Med Chem Lett. 2013 Aug 15;23(16):4608-16.?
molnova catalog
related products
  • BMS-960

    BMS-960 is an S1P agonist with potential anti-tumour activity for cancer research.

  • CYM 5520

    noncompetitive allosteric agonist of S1P2.

  • SK1-IN-1

    SK1-IN-1 is an orally available and potent sphingosine kinase 1 (SPHK1) inhibitor (IC50: 58 nM), with potential anticancer activity, and can be used to study cancer and neurodegenerative diseases.